Spearheads creation and execution of brand strategies, product launch and line expansion, and organizational change management for the Solid Tumor Business Unit including lung cancer, breast cancer, esophageal cancer, precision medicine, and targeted therapies. Directs an 87-member team including 9 Area Sales Leaders and 78 Sales Specialists.• Planned and executed the first ever virtual launch in Novartis history with the launch of Tabrecta. Earned Novartis Impact Award for launch execution and initial success.• Collaborated with cross-functional teams to devise a targeted strategy and cadence for driving sales capabilities and performance within a virtual environment; implemented new platforms, tools, and messaging to empower sales function to maintain customer engagement and meet goals.• Played an integral role in launch readiness through extensive brand planning, message and resource development, value and access account planning, key opinion leader (KOL) identification, and engagement strategy.• Recognized as a Finalist for the PM360 publication Trailblazer Awards for ‘Marketing of the Year’ following virtual product launch and digital transformation during pandemic.• Instituted a diversity and inclusion (D&I) strategy to improve the culture, community, and growth opportunities within Oncology and increase investment in diverse talent.• Partners with key stakeholders to drive top line volume growth across the portfolio of lung and rare disease products.

Expanded executive leadership to encompass entire Western half of the United States with a focus on Neuroscience within Primary Care, Psychiatry, Neurology, and key accounts. Formulated brand strategies to drive demand generation for a $2B+ portfolio. Managed a 432-member sales team including 5 Sales Directors, 40 District Managers, and 387 Sales Representatives.• Orchestrated organizational change management as an executive stakeholder following acquisition of Shire Pharmaceuticals. Integrated sales forces, implemented system changes, and fostered an inclusive environment to promote continued success within 8 months.• Coordinated training on expanded portfolio of Takeda and Shire products to ramp up sales opportunities while maintaining customer trust and meeting sales targets.• Stimulated 28% volume growth for Trintellix and 6% volume growth for Vyvanse after integration.• Oversaw P&L management, formulated incentive and compensation model, and led talent development to cultivate exceptional sales performance.

Selected to build and lead a newly formed National Specialty Sales Division with a focus on Psychiatry, Neurology, and key accounts. Spearheaded development of strategic capabilities for a best-in-class neuroscience organization including demand generation and P&L management. Designed a competitive incentive and compensation model and people development strategy and metrics.• Earned 2017 National Sales Network “Sales Executive Impact Award” for exceptional leadership, performance, and organizational impact.• Recruited and hired top talent at all levels to support a 165-member sales team including 2 Regional Sales Directors, 16 District Managers, and 147 Specialty Sales Representatives.• Designed and presented the Specialty launch strategy and content at one of the most engaging launch meetings to date for Takeda based on learning and engagement metrics.• Drove more than 27% volume growth for 2 consecutive years exceeding brand demand forecast.• Collaborated with Trintellix brand to shape brand strategy and execution of product label updates for Speed for Processing and Treatment Emergent Sexual Dysfunction.• Crafted first Takeda KOL strategy to strengthen partnership with CNS thought leaders and accounts.• Upskilled newly created Specialty Sales Force and improved customer engagement through creation of a comprehensive training curriculum.• Engaged in regular cross-functional collaboration with key stakeholders such as Brand, Manage Markets, Training, HR, Finance, Medical, Compliance, and Alliance Partners.

Established the strategic direction for the New England Region encompassing 7 states and 115 direct reports; shaped the regional culture and expectations to drive improved sales performance across the General Medicine portfolio of products including CNS, GI, and Diabetes.• Improved region performance from #17 of 19 regions to #4 within 6 months through focused strategy leading to consistent portfolio growth.

Empowered top-performing sales region to deliver exceptional sales results and customer value for multi-million-dollar Vyvanse brand. Partnered with sales and marketing teams to shape sales strategies, training capabilities, and marketing resources to optimize the customer and patient experience.• Nominated by team for the prestigious Michael E. Yasick Leadership Award within first year for transforming the culture and morale of the Indianapolis region.• Ranked in top 10% for sales performance through guiding vision and executional strategy for regional directors across a multi-state region.• Targeted the brand strategy and access results for the Adult Binge Eating Disorder indication launch.• Co-developed a national DBM coaching and leadership forum to elevate the skills and coaching abilities of sales leaders.

Served as key stakeholder of executive leadership team supporting Vice President of U.S. Sales/Operations and Vice President of Marketing. Leveraged Lean Six Sigma tools to enhance development of franchise strategies and efficiencies within the Diabetes Business Unit. Drove processes to accelerate brand learnings for future global product launches, assess brand strategy and execution, and devise measurement plans to track progress and mitigation strategies.• Reduced sales operating expenses via streamlined sales cycles.• Championed improved diversity and inclusion initiatives within the Diabetes Business Unit.• Designed new product launch learning loops for Trulicity, Glyxambi, and Jardiance brands to quickly access real-time feedback to enhance brand strategies and execution.• Collaborated on the development of a next generation commercialization model to better connect with and engage physicians and payers in the future.

• Achieved ranking within top 99 percent across Lilly USA in 2013 for employee engagement based upon feedback from direct reports.• Selected as one of 20 individuals to attend the Global Leadership Development Program for executive level talent in 2013 and one of 12 African American leaders selected for the African American Leadership Retreat.